These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31303746)

  • 21. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
    Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
    Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
    Li S; Yang Y; Zou J; Zeng J; Ding C
    BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial.
    Jorge DM; Tavares Neto JEDS; Poli-Neto OB; Scott IU; Jorge R
    Int J Retina Vitreous; 2021 Apr; 7(1):35. PubMed ID: 33902755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy.
    Ushida H; Kachi S; Asami T; Ishikawa K; Kondo M; Terasaki H
    Ophthalmic Res; 2013; 49(1):30-6. PubMed ID: 23038607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intravitreal injection of bevacizumab on inflammatory cytokines in the vitreous with proliferative diabetic retinopathy.
    Suzuki Y; Suzuki K; Yokoi Y; Miyagawa Y; Metoki T; Nakazawa M
    Retina; 2014 Jan; 34(1):165-71. PubMed ID: 23851630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
    Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
    Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
    Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anterior retinal cryotherapy and intravitreal injection of bevacizumab in the treatment of nonclearing vitreous hemorrhage in proliferative diabetic retinopathy.
    Hsieh MC; Yeh PT; Yang CM; Yang CH
    J Ocul Pharmacol Ther; 2014 May; 30(4):353-8. PubMed ID: 24359129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.
    Forooghian F; Kertes PJ; Eng KT; Agrón E; Chew EY
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2388-92. PubMed ID: 20007836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.
    Göncü T; Özdek S; Ünlü M
    Eur J Ophthalmol; 2014; 24(1):88-93. PubMed ID: 23787453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.
    Modarres M; Nazari H; Falavarjani KG; Naseripour M; Hashemi M; Parvaresh MM
    Eur J Ophthalmol; 2009; 19(5):848-52. PubMed ID: 19787608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
    Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
    Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?
    Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
    Eur J Ophthalmol; 2009; 19(4):618-21. PubMed ID: 19551678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
    Gupta A; Bansal R; Gupta V; Dogra MR
    Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
    Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
    Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
    Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
    Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy.
    Ding Y; Su N; Luan J; Ni Y; Sun Z
    J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37108958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy.
    Suzuki Y; Suzuki K; Kudo T; Metoki T; Nakazawa M
    Ophthalmologica; 2016; 236(3):133-138. PubMed ID: 27794575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous humor monocyte chemoattractant protein-1 predicted long-term visual outcome of proliferative diabetic retinopathy undergone intravitreal injection of bevacizumab and vitrectomy.
    Lei J; Ding G; Xie A; Hu Y; Gao N; Fan X
    PLoS One; 2021; 16(3):e0248235. PubMed ID: 33667285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.